BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Shares Outstanding (Diluted) (2020 - 2026)

Updated

BridgeBio Pharma's Weighted Average Shares Outstanding (Diluted) was 196.03 million in Q3 2026, up 2.2% from 191.85 million a year earlier and up 0.1% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding (Diluted) at BridgeBio Pharma came in at 191.53 million, up 2.9% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding (Diluted) was 186.08 million in FY2024 (+14.3%), 162.79 million in FY2023 (+10.4%), 147.47 million in FY2022 (+2.2%) and 144.36 million in FY2021 (+22.3%).
  • The Q3 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2020.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 17 straight quarters, with growth averaging 4.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 0.0% (Q2 2022) to 23.6% (Q1 2022).
  • Per Business Quant data, BBIO's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q3 2026 was 195.79 million (Q2 2026), 194.79 million (Q1 2026) and 191.53 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 196.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 196.03 Mn
Jun 30, 2026 195.79 Mn
Mar 31, 2026 194.79 Mn
Dec 31, 2025 191.53 Mn
Sep 30, 2025 191.85 Mn
Jun 30, 2025 190.52 Mn
Mar 31, 2025 190.15 Mn
Dec 31, 2024 186.08 Mn
Sep 30, 2024 188.51 Mn
Jun 30, 2024 187.59 Mn
Mar 31, 2024 178.71 Mn
Dec 31, 2023 162.79 Mn
Sep 30, 2023 163.31 Mn
Jun 30, 2023 160.54 Mn
Mar 31, 2023 152.65 Mn
Dec 31, 2022 147.47 Mn
Sep 30, 2022 147.94 Mn
Jun 30, 2022 146.68 Mn
Mar 31, 2022 145.88 Mn
Dec 31, 2021 144.36 Mn
API Access

BridgeBio Pharma Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BBIO&period=max&api_key=YOUR_API_KEY